1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required/Optional) is sponsored by National Institutes of Health (NIH) / National Institute on Drug Abuse (NIDA) / National Institute of Neurological Disorders and Stroke (NINDS). This omnibus solicitation provides opportunities for small businesses to engage in research and development that has the potential for commercialization and public health impact.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) Agency: National Institutes of Health Assistance Listings: 93.
233 -- National Center on Sleep Disorders Research 93. 867 -- Vision Research 93. 307 -- Minority Health and Health Disparities Research 93.
273 -- Alcohol Research Programs 93. 879 -- Medical Library Assistance 93. 173 -- Research Related to Deafness and Communication Disorders 93.
172 -- Human Genome Research 93. 286 -- Discovery and Applied Research for Technological Innovations to Improve Human Health 93. 838 -- Lung Diseases Research 93.
837 -- Cardiovascular Diseases Research 93. 113 -- Environmental Health 93. 242 -- Mental Health Research Grants 93.
142 -- NIEHS Hazardous Waste Worker Health and Safety Training 93. 213 -- Research and Training in Complementary and Integrative Health 93. 840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders 93.
865 -- Child Health and Human Development Extramural Research 93. 393 -- Cancer Cause and Prevention Research 93. 361 -- Nursing Research 93.
847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research 93. 143 -- NIEHS Superfund Hazardous Substances_Basic Research and Education 93. 394 -- Cancer Detection and Diagnosis Research 93.
839 -- Blood Diseases and Resources Research 93. 395 -- Cancer Treatment Research Last Updated: May 13, 2026 View version history on Grants. gov This Notice of Funding Opportunity Announcement (NOFO), issued by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications.
United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH and CDC awarding components identified in this NOFO are encouraged to submit SBIR grant applications in response to identified topics (see SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA).
This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. Grantor contact information See Section VII.
Agency Contacts within the full opportunity announcement for all other inquires. File name Description Last updated PA-24-246-Full-Announcement. html PA-24-246 Full Announcement Text Link to additional information https://grants.
nih. gov/grants/guide/pa-files/PA-24-246. html Archived: October 5, 2025 Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Income security and social services Your account requires additional identity verification.
According to the current listing, eligibility includes: Small business concerns. Confirm the full requirements in the official notice before applying.
The current listing shows normally may not exceed $306,872 for Phase I, and $2,045,816 for Phase II, unless proposal falls under one of the approved topics. Verify award ceilings, matching requirements, and allowable costs in the official notice.
PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required/Optional) is funded by National Institutes of Health (NIH) / National Institute on Drug Abuse (NIDA) / National Institute of Neurological Disorders and Stroke (NINDS). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read article